JENNY LUONG: Open Payments
NPI 1316281280 · IRVINE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$496 in 10 payments from 6 companies in 2025. Trend: 2023 $347 · 2024 $492 · 2025 $496
Food & beverage: $496
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $165 |
| AstraZeneca Pharmaceuticals LP | 1 | $123 |
| Novo Nordisk Inc | 1 | $121 |
| Amgen Inc. | 3 | $48 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $19 |
Products named: BREZTRI, ZEPBOUND, TEZSPIRE, MOUNJARO, SHINGRIX, M-M-R II.
Industry payments across CA — which companies pay providers there.
